122 related articles for article (PubMed ID: 36137619)
1. Three birds with one stone: a protocol for a randomised intervention study to increase participation in cervical and colorectal cancer screening among women attending breast cancer screening.
Helgestad ADL; Larsen MB; Njor S; Tranberg M; Petersen LK; Andersen B
BMJ Open; 2022 Sep; 12(9):e062824. PubMed ID: 36137619
[TBL] [Abstract][Full Text] [Related]
2. Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study.
Tranberg M; Petersen LK; Elfström KM; Hammer A; Blaakær J; Bennetsen MH; Jensen JS; Andersen B
BMJ Open; 2020 Nov; 10(11):e039636. PubMed ID: 33154056
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of novel screening strategies for colorectal cancer screening in China (TARGET-C): a study protocol for a multicentre randomised controlled trial.
Chen H; Li N; Shi J; Ren J; Liu C; Zhang Y; Jiang Z; Zhang Z; Dai M
BMJ Open; 2019 Apr; 9(4):e025935. PubMed ID: 31005927
[TBL] [Abstract][Full Text] [Related]
4. The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care.
Saya S; Boyd L; Chondros P; McNamara M; King M; Milton S; Lourenco RA; Clark M; Fishman G; Marker J; Ostroff C; Allman R; Walter FM; Buchanan D; Winship I; McIntosh J; Macrae F; Jenkins M; Emery J
Trials; 2022 Sep; 23(1):810. PubMed ID: 36163034
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection.
Fujita M; Shimazu M; Nagashima K; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Shozu M; Hanaoka H; Tsuruoka N; Kasai T; Hata A
BMJ Open; 2022 Feb; 12(2):e049803. PubMed ID: 35115348
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
[TBL] [Abstract][Full Text] [Related]
7. Increasing uptake of FIT colorectal screening: protocol for the TEMPO randomised controlled trial testing a suggested deadline and a planning tool.
Robb KA; Kotzur M; Young B; McCowan C; Hollands GJ; Irvine A; Macdonald S; McConnachie A; O'Carroll RE; O'Connor RC; Steele RJC
BMJ Open; 2023 May; 13(5):e066136. PubMed ID: 37202130
[TBL] [Abstract][Full Text] [Related]
8. Text messaging as a tool to improve cancer screening programs (M-TICS Study): A randomized controlled trial protocol.
Vives N; Farre A; Ibáñez-Sanz G; Vidal C; Binefa G; Milà N; Pérez-Lacasta MJ; Travier N; Benito L; Espinàs JA; Bagaria G; Garcia M
PLoS One; 2021; 16(1):e0245806. PubMed ID: 33481914
[TBL] [Abstract][Full Text] [Related]
9. Colon capsule endoscopy in colorectal cancer screening: a randomised controlled trial.
Kaalby L; Deding U; Kobaek-Larsen M; Havshoi AV; Zimmermann-Nielsen E; Thygesen MK; Kroeijer R; Bjørsum-Meyer T; Baatrup G
BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32601101
[TBL] [Abstract][Full Text] [Related]
10. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
[TBL] [Abstract][Full Text] [Related]
11. Randomised trial to evaluate the effectiveness and impact of offering postvisit decision support and assistance in obtaining physician-recommended colorectal cancer screening: the e-assist: Colon Health study-a protocol study.
Lafata JE; Shin Y; Flocke SA; Hawley ST; Jones RM; Resnicow K; Schreiber M; Shires DA; Tu SP
BMJ Open; 2019 Jan; 9(1):e023986. PubMed ID: 30617102
[TBL] [Abstract][Full Text] [Related]
12. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
13. Randomized, controlled trial of a multimodal intervention to improve cancer screening rates in a safety-net primary care practice.
Hendren S; Winters P; Humiston S; Idris A; Li SX; Ford P; Specht R; Marcus S; Mendoza M; Fiscella K
J Gen Intern Med; 2014 Jan; 29(1):41-9. PubMed ID: 23818159
[TBL] [Abstract][Full Text] [Related]
14. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
[TBL] [Abstract][Full Text] [Related]
16. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
17. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain.
Lo SH; Waller J; Wardle J; von Wagner C
J Med Screen; 2013 Jun; 20(2):73-9. PubMed ID: 23761420
[TBL] [Abstract][Full Text] [Related]
18. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG
Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080
[TBL] [Abstract][Full Text] [Related]
19. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.
Guiriguet C; Muñoz-Ortiz L; Burón A; Rivero I; Grau J; Vela-Vallespín C; Vilarrubí M; Torres M; Hernández C; Méndez-Boo L; Toràn P; Caballeria L; Macià F; Castells A
Br J Gen Pract; 2016 Jul; 66(648):e483-90. PubMed ID: 27266861
[TBL] [Abstract][Full Text] [Related]
20. Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial.
Spees LP; Des Marais AC; Wheeler SB; Hudgens MG; Doughty S; Brewer NT; Smith JS
Trials; 2019 Dec; 20(1):788. PubMed ID: 31881928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
